CO5611115A2 - Proceso para la produccion de propionato de fluticasona, en particular de la forma polimorfica 1 - Google Patents
Proceso para la produccion de propionato de fluticasona, en particular de la forma polimorfica 1Info
- Publication number
- CO5611115A2 CO5611115A2 CO04074014A CO04074014A CO5611115A2 CO 5611115 A2 CO5611115 A2 CO 5611115A2 CO 04074014 A CO04074014 A CO 04074014A CO 04074014 A CO04074014 A CO 04074014A CO 5611115 A2 CO5611115 A2 CO 5611115A2
- Authority
- CO
- Colombia
- Prior art keywords
- fluticasone propionate
- polymorphic form
- organic liquid
- solvating
- solution
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
1.- Un proceso para preparar propionato de fluticasona en la forma polimórfica 1, que comprende mezclar una solución de propionato de fluticasona en un disolvente líquido orgánico no solvatante con un antidisolvente líquido orgánico no solvatante, causando así que el propionato de fluticasona cristalice de la solución como la forma polimórfica cristalina 1.4.- Un proceso para preparar propionato de fluticasona en la forma polimórfica cristalina 1, que comprende:a) hacer reaccionar un compuesto de fórmula (II) o una sal del mismo con un compuesto de fórmula LCH2F, en la que L representa un grupo saliente, opcionalmente en presencia de un catalizador de transferencia de fases, un disolvente líquido orgánico no solvatante inmiscible con agua y agua;b) aumentar opcionalmente la pureza del propionato de fluticasona en la fase orgánica realizando una o más etapas de lavado acuoso;c) separar la fase orgánica de la fase acuosa y concentrar opcionalmente el propionato de fluticasona en la fase orgánica;d) mezclar la solución de propionato de fluticasona en el disolvente líquido orgánico no solvatante inmiscible con agua presente en la fase orgánica con un antidisolvente líquido orgánico no solvatante, causando así que el propionato de fluticasona cristalice de la solución en la forma polimórfica cristalina 1.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0202564.1A GB0202564D0 (en) | 2002-02-04 | 2002-02-04 | Process |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5611115A2 true CO5611115A2 (es) | 2006-02-28 |
Family
ID=9930366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO04074014A CO5611115A2 (es) | 2002-02-04 | 2004-07-30 | Proceso para la produccion de propionato de fluticasona, en particular de la forma polimorfica 1 |
Country Status (22)
Country | Link |
---|---|
US (1) | US20050222107A1 (es) |
EP (1) | EP1474436B1 (es) |
JP (1) | JP2005517019A (es) |
KR (1) | KR20040086331A (es) |
CN (1) | CN100338087C (es) |
AR (1) | AR038390A1 (es) |
AT (1) | ATE446965T1 (es) |
AU (1) | AU2003206836B2 (es) |
BR (1) | BR0307243A (es) |
CA (1) | CA2473896A1 (es) |
CO (1) | CO5611115A2 (es) |
DE (1) | DE60329824D1 (es) |
GB (1) | GB0202564D0 (es) |
IS (1) | IS7373A (es) |
MX (1) | MXPA04007530A (es) |
NO (1) | NO327138B1 (es) |
NZ (1) | NZ534320A (es) |
PL (1) | PL372214A1 (es) |
RU (1) | RU2333218C2 (es) |
TW (1) | TW200410982A (es) |
WO (1) | WO2003066653A2 (es) |
ZA (1) | ZA200405826B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL153462A0 (en) * | 2002-12-16 | 2003-07-06 | Chemagis Ltd | Thiocarboxylic acid organic salts and processes utilizing the same |
PT2044099E (pt) * | 2006-06-14 | 2012-06-06 | Generics Uk Ltd | Processo de preparação s-fluorometil-6,9-difluoro-11- hidroxi-16-metil-17-propioniloxi-3-oxo-androsta-l,4- dieno-17-carbotioato e seus intermediários |
AU2013202835B2 (en) * | 2006-06-14 | 2015-11-12 | Generics [Uk] Limited | Process for the preparation of S-fluoromethyl-6,9-difluoro-11-hydroxy-16-methyl-17-propionyloxy-3-oxo-androsta-1, 4-diene-17-carbothioate and intermediates |
WO2012029077A2 (en) * | 2010-09-01 | 2012-03-08 | Cadila Healthcare Limited | Process for preparing fluticasone propionate/furoate |
JP2014520848A (ja) * | 2011-07-08 | 2014-08-25 | ファイザー・リミテッド | 1型プロピオン酸フルチカゾンの調製のための方法 |
CA2872845C (en) | 2012-05-08 | 2021-11-09 | Aciex Therapeutics, Inc. | Preparation of nanocrystals of fluticasone propionate |
US8765725B2 (en) | 2012-05-08 | 2014-07-01 | Aciex Therapeutics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
DE102012221219B4 (de) * | 2012-11-20 | 2014-05-28 | Jesalis Pharma Gmbh | Verfahren zur Vergrößerung der Partikelgröße kristalliner Wirkstoff-Mikropartikel |
US9815865B2 (en) | 2013-01-07 | 2017-11-14 | Nicox Ophthalmics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2455976A1 (de) * | 1974-11-27 | 1976-08-12 | Merck Patent Gmbh | Prostensaeurederivate |
PH24267A (en) * | 1980-02-15 | 1990-05-29 | Glaxo Group Ltd | Androstane carbothioates and pharmaceutical compositions containing the same |
US5783677A (en) * | 1993-09-24 | 1998-07-21 | Procter & Gamble Pharmaceuticals, Inc. | Deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds |
US5488188A (en) * | 1994-09-29 | 1996-01-30 | Merrell Dow Pharmaceuticals Inc. | Process for the preparation of (E)-1-amino-2-(fluoromethylene)-4-(p-fluorophenyl)butane, novel processes for preparing an intermediate thereof, and novel intermediates thereof |
GB9622173D0 (en) * | 1996-10-24 | 1996-12-18 | Glaxo Group Ltd | Particulate Products |
GB9925934D0 (en) * | 1999-11-03 | 1999-12-29 | Glaxo Group Ltd | Novel apparatus and process |
AP1422A (en) * | 2000-08-05 | 2005-06-05 | Glaxo Group Ltd | 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent. |
-
2002
- 2002-02-04 GB GBGB0202564.1A patent/GB0202564D0/en not_active Ceased
-
2003
- 2003-01-30 TW TW092102249A patent/TW200410982A/zh unknown
- 2003-01-31 AR ARP030100299A patent/AR038390A1/es not_active Application Discontinuation
- 2003-02-03 US US10/502,866 patent/US20050222107A1/en not_active Abandoned
- 2003-02-03 AT AT03704541T patent/ATE446965T1/de not_active IP Right Cessation
- 2003-02-03 PL PL03372214A patent/PL372214A1/xx unknown
- 2003-02-03 AU AU2003206836A patent/AU2003206836B2/en not_active Ceased
- 2003-02-03 CA CA002473896A patent/CA2473896A1/en not_active Abandoned
- 2003-02-03 JP JP2003566024A patent/JP2005517019A/ja active Pending
- 2003-02-03 EP EP03704541A patent/EP1474436B1/en not_active Expired - Lifetime
- 2003-02-03 DE DE60329824T patent/DE60329824D1/de not_active Expired - Fee Related
- 2003-02-03 WO PCT/EP2003/001115 patent/WO2003066653A2/en active Application Filing
- 2003-02-03 CN CNB038074370A patent/CN100338087C/zh not_active Expired - Fee Related
- 2003-02-03 BR BR0307243-6A patent/BR0307243A/pt not_active IP Right Cessation
- 2003-02-03 NZ NZ534320A patent/NZ534320A/en unknown
- 2003-02-03 KR KR10-2004-7011981A patent/KR20040086331A/ko not_active Application Discontinuation
- 2003-02-03 RU RU2004122928/04A patent/RU2333218C2/ru not_active IP Right Cessation
- 2003-02-03 MX MXPA04007530A patent/MXPA04007530A/es active IP Right Grant
-
2004
- 2004-07-21 ZA ZA200405826A patent/ZA200405826B/en unknown
- 2004-07-26 IS IS7373A patent/IS7373A/is unknown
- 2004-07-30 CO CO04074014A patent/CO5611115A2/es not_active Application Discontinuation
- 2004-09-01 NO NO20043664A patent/NO327138B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IS7373A (is) | 2004-07-26 |
KR20040086331A (ko) | 2004-10-08 |
NO327138B1 (no) | 2009-05-04 |
ZA200405826B (en) | 2005-08-11 |
AU2003206836B2 (en) | 2009-01-08 |
TW200410982A (en) | 2004-07-01 |
BR0307243A (pt) | 2004-12-14 |
ATE446965T1 (de) | 2009-11-15 |
AU2003206836A1 (en) | 2003-09-02 |
PL372214A1 (en) | 2005-07-11 |
US20050222107A1 (en) | 2005-10-06 |
CN100338087C (zh) | 2007-09-19 |
WO2003066653A2 (en) | 2003-08-14 |
AR038390A1 (es) | 2005-01-12 |
CA2473896A1 (en) | 2003-08-14 |
NZ534320A (en) | 2007-07-27 |
EP1474436A2 (en) | 2004-11-10 |
EP1474436B1 (en) | 2009-10-28 |
MXPA04007530A (es) | 2004-11-10 |
WO2003066653A3 (en) | 2003-12-24 |
GB0202564D0 (en) | 2002-03-20 |
JP2005517019A (ja) | 2005-06-09 |
RU2333218C2 (ru) | 2008-09-10 |
CN1642969A (zh) | 2005-07-20 |
RU2004122928A (ru) | 2005-05-27 |
NO20043664L (no) | 2004-09-01 |
DE60329824D1 (de) | 2009-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR035992A1 (es) | Proceso para producir acido tereftalico puro con recuperacion mejorada de precursores, solvente y metil acetato | |
CO5611115A2 (es) | Proceso para la produccion de propionato de fluticasona, en particular de la forma polimorfica 1 | |
BRPI0812625A2 (pt) | processo para preparar um sal de cis-atracúrio | |
AR063415A1 (es) | Hidratos de clorhidrato de erlotinib para el tratamiento del cancer | |
CN103788069B (zh) | 埃索美拉唑镁三水合物的制备方法 | |
BRPI0616169B8 (pt) | cloridrato de lercanidipina na forma polimorfa v, composição farmacêutica compreendendo dito composto e processos para preparação de cloridrato de lercanidipina | |
NO20090748L (no) | Fremgangsmate for rensing av montelukast | |
ATE266020T1 (de) | Synthese von r-(+)-alpha-liponsäure | |
BRPI0615131A2 (pt) | preparação de tioalquilaminas com rendimentos elevados | |
CN102887853A (zh) | 一种群多普利中间体的制备方法 | |
CN104311459A (zh) | 一种氧化不对称硫醚制备亚砜的方法 | |
AR029002A1 (es) | Proceso para preparar compuestos de acidos quinolin-2-carboxilicos y de sus sales farmaceuticamente aceptables | |
AR014939A1 (es) | Proceso para purificar una solucion de un ester profarmaco de ampicilina | |
CN103351311A (zh) | 一种二苯乙腈的合成方法 | |
ES2195925T3 (es) | Proceso para fabricar una formulacion de liberacion retardada. | |
JP2009007257A (ja) | ケルセチン含有植物材料を用いたケルセチンスルホン酸の製造方法 | |
PE20060203A1 (es) | Sintesis de pirrol-2-carbonitrilos | |
BRPI0713347A2 (pt) | Processo para produção de composto de álcool | |
TH1701005612A (th) | สีย้อมอินทรีย์จากอนุพันธ์ของสารประกอบ 13-((n-ออกโซอัลคิล)ออกซี)ไดเบนโซ[c,g]ฟีแนนทรีน-3,4-ไดคาร์โบไนไตรล์ สำหรับใช้เป็นโมเลกุลแสดงสัญญาณเพื่อการตรวจวัด และกรรมวิธีการสังเคราะห์สารประกอบดังกล่าว | |
CN104592178A (zh) | 一种脱氢枞酸内酯的制备方法 | |
DE60127455D1 (de) | Verfahren zur herstellung von beta-ketonitrilverbindungen | |
BRPI0713345A2 (pt) | Processo para produção de composto de álcool | |
CN107098868B (zh) | 一种帕立骨化醇中间体的制备方法 | |
AR105700A1 (es) | Sal de (s)-csa de s-ketamina, sal de (r)-csa de s-ketamina y procesos para la preparación de s-ketamina | |
TH149857A (es) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |